3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
5
Lymphoma, Large B-Cell, Diffuse
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Multiple Myeloma
4
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
2
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Breast Neoplasms
2
Plasmacytoma
1
Nasopharyngeal Carcinoma
1
Meningeal Carcinomatosis
1
Lymphoma
1
Liver Neoplasms
1
Glioma
1
Carcinoma, Hepatocellular
1
Burkitt Lymphoma
1
Brain Neoplasms
1
Interventions
fludarabine
27
Azacitidine
26
venetoclax
23
Cyclophosphamide
22
Specimen Handling
21
fludarabine phosphate
17
Biopsy
16
Whole-Body Irradiation
15
Mycophenolic Acid
15
Busulfan
15
Melphalan
14
Cytarabine
14
Tacrolimus
13
Granulocyte Colony-Stimulating Factor
12
Decitabine
11
Stem Cell Transplantation
10
Injections
10
Cyclosporine
10
decitabine and cedazuridine drug combination
9
Sirolimus
9
Filgrastim
9
Peripheral Blood Stem Cell Transplantation
8
Thiotepa
7
X-Rays
6
Idarubicin
6
ruxolitinib
5
Cyclosporins
5
Cladribine
5
Methotrexate
4
Magnetic Resonance Spectroscopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Immunotherapy, Adoptive
×
90 days
×
Clear all
No trials found.